Progressively increasing PSV and ICA/CCA ratios correlate with evolving restenosis within the stented carotid artery. Ultrasound velocity criteria developed for native arteries overestimate the degree of in-stent restenosis encountered. These changes persist during long-term follow-up and across all grades of in-stent restenosis after CAS. The proposed new velocity criteria accurately define residual stenosis >or =20%, in-stent restenosis >or =50%, and high-grade in-stent restenosis > or =80% in the stented carotid artery.

The concept of the high-risk CEA must be critically reexamined. Although 29% of patients for CEA were high risk as defined by others, we found no evidence that this influenced the results after CEA. Patients with significant medical comorbidities, contralateral carotid occlusion, and high carotid lesions can undergo operation without increased complications. If a high-risk group exists, it is small and restricted to reoperation or radiated neck (4% in this series). With this possible exception, carotid angioplasty stenting should be restricted to randomized clinical trials.

The proposed classification accurately grades the magnitude of intimal hyperplasia after CAS and provides important prognostic information. Diffuse proliferative (type IV) ISR lesions and diabetes are important determinants of long-term outcome after CAS. This classification will facilitate a standardized description of recurrence after CAS and enable early identification of high-risk patients for additional monitoring, treatment, and investigation.